290 related articles for article (PubMed ID: 10697358)
1. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
Bar MH
Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
[No Abstract] [Full Text] [Related]
2. Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.
Livingston R; Crowley J
J Clin Oncol; 1999 Nov; 17(11 Suppl):22-4. PubMed ID: 10630257
[No Abstract] [Full Text] [Related]
3. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
5. Dose intensification and breast cancer.
Khayat D; Antoine E
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():153-77. PubMed ID: 9210898
[No Abstract] [Full Text] [Related]
6. High-dose therapy in breast cancer: out of favor but not out of promise.
Glück S; Stewart D
Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN
Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.
Bearman SI; Shpall EJ; Jones RB; Cagnoni PJ; Ross M
Semin Oncol; 1996 Feb; 23(1 Suppl 2):60-7. PubMed ID: 8614848
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
Zander AR; Kröger N; Schmoor C; Krüger W; Möbus V; Frickhofen N; Metzner B; Schultze W; Berdel WE; Koenigsmann M; Thiel E; Wandt H; Possinger K; Trümper L; Kreienberg R; Carstensen M; Schmidt EH; Jänicke F; Schumacher M; Jonat W
J Clin Oncol; 2004 Jun; 22(12):2273-83. PubMed ID: 15111618
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.
Kim YS; Konoplev SN; Montemurro F; Hoy E; Smith TL; Rondón G; Champlin RE; Sahin AA; Ueno NT
Clin Cancer Res; 2001 Dec; 7(12):4008-12. PubMed ID: 11751494
[TBL] [Abstract][Full Text] [Related]
11. [High dosage chemotherapy and peripheral blood stem cell transplantation in breast carcinoma].
Jentsch-Ullrich K; Höffken HG; Franke A
Zentralbl Chir; 1998; 123 Suppl 5():162-4. PubMed ID: 10063605
[TBL] [Abstract][Full Text] [Related]
12. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors].
Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V
Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806
[TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
[TBL] [Abstract][Full Text] [Related]
15. [High-dose chemotherapy with hematopoietic stem-cell support in breast cancer].
Viens P; Maraninchi D
Bull Cancer; 2001 Sep; 88(9):835-41. PubMed ID: 11604355
[No Abstract] [Full Text] [Related]
16. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
Maraninchi D; Droz JP
Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
[TBL] [Abstract][Full Text] [Related]
18. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed.
Vogl DT; Stadtmauer EA
Bone Marrow Transplant; 2006 Jun; 37(11):985-7. PubMed ID: 16708060
[No Abstract] [Full Text] [Related]
20. [High-dose chemotherapy with hemopoietic progenitor cell support: new outlooks in the treatment of breast cancer].
Sola C; Alonso MC; López López JJ
Med Clin (Barc); 1995 May; 104(18):702-8. PubMed ID: 7769882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
